Concepedia

Deen Tulshian

DT

50

Publications

1.6K

Citations

24

H-Index

1981

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

AGCO (United Kingdom)

Albany Molecular Research (United States)

Institute of Neurobiology

San Raffaele University of Rome

Deen Tulshian is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1981–2016

50

Publications

50

Potent, selective, and orally active adenosine A2A receptor antagonists: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines

Bernard R. Neustadt, Jinsong Hao, Neil Lindo et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 135 citations · Full text

, , +4

Nociceptin inhibits cough in the guinea‐pig by activation of ORL<sub>1</sub> receptors

Robbie L. McLeod, Leonard E. Parra, Jennifer C. Mutter et al. · British Journal of Pharmacology · 2001 · 99 citations · Full text

, , +16

Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species

Geoffrey B. Varty, Lynn A. Hyde, Robert A. Hodgson et al. · Psychopharmacology · 2005 · 83 citations

, , +10

The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)

Geoffrey B. Varty, Sherry Lu, Cynthia A. Morgan et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 83 citations

SCH-202676: An Allosteric Modulator of Both Agonist and Antagonist Binding to G Protein-Coupled Receptors

Ahmad Fawzi, Douglas Macdonald, Lawrence L. Benbow et al. · Molecular Pharmacology · 2001 · 80 citations

Rows per page

1–5 of 50